Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 402-405

  García Lerma, J Gerardo ^a   Soriano, Vincent ^b   Mas, Antonio ^b,d   Quiñones Mateu, Miguel E ^c   Arts, Eric J ^c   Heneine, Walid ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; STAVUDINE; VIRUS ENZYME;

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIREMIA; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; GUINEA; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; INDINAVIR; LAMIVUDINE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SPAIN; STAVUDINE; VIRAL LOAD; VIREMIA;

EID: 0342632827     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. DeGruttola, V., M. Hughes, P. Gilbert, and A. Phillips. 1998. Trial design in the era of highly effective antiviral drug combinations for HIV infection. AIDS 12(Suppl. A):S149-S156.
2. Descamps, D., G. Collin, F. Letourneur, C. Apetrei, F. Damond, I. Loussert-Ajaka, F. Simon, S. Saragosti, and F. Brun-Vézinet. 1997. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J. Virol. 71:8893-8898.
3. García Lerma, J. G., M. Gutierrez, A. Mas, R. Bravo, O. Aguilera, and V. Soriano. 1996. Report of the first two cases of HIV-1 group O infection in Spain. Med. Clin. 107:418-421.
4. García Lerma, J. G., S. Yamamoto, M. Gómez-Cano, V. Soriano, T. A. Green, M. P. Busch, T. M. Folks, and W. Heneine. 1998. Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: evidence of variabilities in levels of virion-associated RT. J. Infect. Dis. 177:1221-1229.
5. García Lerma, J. G., R. F. Schinazi, A. S. Juodawlkis, V. Soriano, Y. Lin, K. Tatti, D. Rimland, T. M. Folks, and W. Heneine. 1999. A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC). Antimicrob. Agents Chemother. 43:264-270.
6. Gobbers, E., K. Fransen, T. Oosterlaken, W. Janssens, L. Heyndrickx, T. Ivens, K. Vereecken, R. Schoones, P. van de Wiel, and G. van der Groen. 1997. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J. Virol. Methods 66:293-301.
7. Heneine, W., S. Yamamoto, W. M. Switzer, T. J. Spira, and T. M. Folks. 1995. Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1. J. Infect. Dis. 171:1210-1216.
8. Jaffe, H. W., and G. Schochetman. 1998. Group O human immunodeficiency virus-1 infections. Infect. Dis. Clin. N. Am. 12:39-46.
9. Leitner, T. 1996. Genetic subtypes of HIV-1, sect. III, p. 28. In G. Myers, B. Korber, B. Foley, et al. (ed.), Human retroviruses and AIDS 1996. Los Alamos National Laboratory, Los Alamos, N. Mex.
10. Nkengasong, J. N., K. Fransen, B. Willens, E. Karita, J. Vingerhoets, L. Kestens, R. Colebunders, P. Piot, and G. van der Groen. 1997. Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J. Med. Virol. 51:202-209.
11. Quiñones-Mateu, M. E., V. Soriano, E. Domingo, and L. Menéndez-Arias. 1997. Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate. Virology 236:364-373.
12. Quiñones-Mateu, M. E., J. L. Albright, A. Mas, V. Soriano, and E. J. Arts. 1998. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1. J. Virol. 72:9002-9015.
13. Respess, R. A., A. Butcher, H. Wang, T. Chaowanachan, N. Young, N. Shaffer, T. D. Mastro, B. Biryahwaho, R. Downing, A. Tanuri, M. Schechter, R. Pascu, L. Zekeng, I. Kaptué, L. Gürtler, J. Eberle, D. Ellenberger, C. Fridlund, M. Rayfield, and S. Kwok. 1997. Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR. J. Clin. Microbiol. 35:1284-1286.
14. Segondy, M., T.-D. Ly, M. Lapeyre, and B. Montes. 1998. Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma. J. Clin. Microbiol. 36:3372-3374.
15. Simon, F., P. Mauclère, P. Rosques, I. Loussert-Ajaka, M. C. Müller-Trutwin, S. Saragosti, M. C. Georges-Courbot, F. Barré-Sinoussi, and F. Brun-Vézinet. 1998. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4:1032-1037.
16. Vallejo, A., A. Heredia, A. Mas, S. F. Lee, J. S. Epstein, V. Soriano, and I. K. Hewlett. 1998. Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:417-425.
17. Vázquez-Rosales, J. G., J. G. García Lerma, S. Yamamoto, W. M. Switzer, D. Havlir, T. M. Folks, D. D. Richman, and W. Heneine. 1999. Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV-1 reverse transcriptase activity in plasma. AIDS Res. Hum. Retrovir. 15:1191-1200.